Jubilant Life’s US arm inks pact with Belgium's Janssen Pharmaceutica

29 Jun 2011 Evaluate

Jubilant Life Sciences’ US-based arm Jubilant Discovery Services has entered into an agreement with Janssen Pharmaceutica NV to deliver pre-clinical candidates in the area of neuroscience to the Belgium-based firm. The agreement will cover an initial period of three years and will focus on multiple targets in the area of neuroscience.

According to the agreement, Janssen will transfer ongoing efforts on selected drug discovery targets to Jubilant and Jubilant will then carry out the research services and deliver pre-clinical candidates to Janssen for possible further development and commercialization. As per the deal in addition to research funding, Jubilant may also be eligible to receive payments at different intervals and royalties should Janssen successfully develop and commercialize the candidates.

The association will utilize Jubilant's global research network to include its new research facility in the US focused in the area of neuroscience, in addition to its India-based research centres.

Jubilant Pharmova Share Price

837.15 3.90 (0.47%)
05-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1782.90
Dr. Reddys Lab 1313.05
Cipla 1326.00
Zydus Lifesciences 914.45
Lupin 2332.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×